JP2024526820A5 - - Google Patents
Info
- Publication number
- JP2024526820A5 JP2024526820A5 JP2024502611A JP2024502611A JP2024526820A5 JP 2024526820 A5 JP2024526820 A5 JP 2024526820A5 JP 2024502611 A JP2024502611 A JP 2024502611A JP 2024502611 A JP2024502611 A JP 2024502611A JP 2024526820 A5 JP2024526820 A5 JP 2024526820A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- fusion protein
- composition according
- actrii
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163223265P | 2021-07-19 | 2021-07-19 | |
| US63/223,265 | 2021-07-19 | ||
| PCT/US2022/037479 WO2023003815A1 (en) | 2021-07-19 | 2022-07-18 | Actrii proteins and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024526820A JP2024526820A (ja) | 2024-07-19 |
| JP2024526820A5 true JP2024526820A5 (https=) | 2025-07-17 |
Family
ID=84979535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024502611A Pending JP2024526820A (ja) | 2021-07-19 | 2022-07-18 | Ａｃｔｒｉｉタンパク質およびその用途 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20240327494A1 (https=) |
| EP (1) | EP4373577A4 (https=) |
| JP (1) | JP2024526820A (https=) |
| KR (1) | KR20240049857A (https=) |
| CN (1) | CN117957014A (https=) |
| AU (1) | AU2022316103A1 (https=) |
| CA (1) | CA3225613A1 (https=) |
| CL (1) | CL2024000151A1 (https=) |
| CO (1) | CO2024001551A2 (https=) |
| CR (1) | CR20240061A (https=) |
| DO (1) | DOP2024000016A (https=) |
| EC (1) | ECSP24012819A (https=) |
| GE (1) | GEAP202416461A (https=) |
| IL (1) | IL310141A (https=) |
| JO (1) | JOP20240010A1 (https=) |
| MX (1) | MX2024000829A (https=) |
| PE (1) | PE20240777A1 (https=) |
| WO (1) | WO2023003815A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021189010A1 (en) | 2020-03-20 | 2021-09-23 | Keros Therapeutics, Inc. | Methods of using activin receptor type iib variants |
| WO2021189019A1 (en) | 2020-03-20 | 2021-09-23 | Keros Therapeutics, Inc. | Activin receptor type ii chimeras and methods of use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180055822A1 (en) * | 2015-03-13 | 2018-03-01 | Repoceuticals Aps | Melatonin for Preventing and Treating Radiation Cystitis |
| EP3380121B1 (en) * | 2015-11-23 | 2023-12-20 | Acceleron Pharma Inc. | Actrii antagonist for use in treating eye disorders |
| DK3496739T3 (da) * | 2016-07-15 | 2021-05-10 | Acceleron Pharma Inc | Sammensætninger omfattende actriia-polypeptider til brug i behandlingen af pulmonal hypertension |
-
2022
- 2022-07-18 PE PE2024000111A patent/PE20240777A1/es unknown
- 2022-07-18 EP EP22846466.5A patent/EP4373577A4/en active Pending
- 2022-07-18 CR CR20240061A patent/CR20240061A/es unknown
- 2022-07-18 US US18/580,425 patent/US20240327494A1/en active Pending
- 2022-07-18 JP JP2024502611A patent/JP2024526820A/ja active Pending
- 2022-07-18 CA CA3225613A patent/CA3225613A1/en active Pending
- 2022-07-18 WO PCT/US2022/037479 patent/WO2023003815A1/en not_active Ceased
- 2022-07-18 MX MX2024000829A patent/MX2024000829A/es unknown
- 2022-07-18 IL IL310141A patent/IL310141A/en unknown
- 2022-07-18 GE GEAP202416461A patent/GEAP202416461A/en unknown
- 2022-07-18 KR KR1020247005282A patent/KR20240049857A/ko active Pending
- 2022-07-18 AU AU2022316103A patent/AU2022316103A1/en active Pending
- 2022-07-18 CN CN202280060109.7A patent/CN117957014A/zh active Pending
-
2024
- 2024-01-17 CL CL2024000151A patent/CL2024000151A1/es unknown
- 2024-01-18 DO DO2024000016A patent/DOP2024000016A/es unknown
- 2024-01-18 JO JOJO/P/2024/0010A patent/JOP20240010A1/ar unknown
- 2024-02-14 CO CONC2024/0001551A patent/CO2024001551A2/es unknown
- 2024-02-19 EC ECSENADI202412819A patent/ECSP24012819A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017538395A5 (https=) | ||
| JP2024526820A5 (https=) | ||
| US9700595B2 (en) | Liquid formulation of a fusion protein comprising TNFR and Fc region | |
| JP2016534052A5 (https=) | ||
| JP2023040169A5 (https=) | ||
| JP2021534220A5 (https=) | ||
| JP2016536369A5 (https=) | ||
| JP2008500373A5 (https=) | ||
| RU2007119989A (ru) | Композиции, слитые конструкции и конъюгаты plad домена | |
| JP2018501201A5 (https=) | ||
| JP2023545707A5 (https=) | ||
| JP2021514354A5 (https=) | ||
| US5660826A (en) | Therapeutic sepsis treatment using antagonists to PTHrP | |
| JP2025518227A (ja) | ｍａｚｄｕｔｉｄｅを使用する治療方法 | |
| JP2017524675A5 (https=) | ||
| CN112390884B (zh) | Semaphorin7A单克隆抗体及其在制备用于治疗炎症疾病药物方面的应用 | |
| JP2023526218A5 (https=) | ||
| FI114011B (fi) | Suonensisäiseen käyttöön tarkoitetun immunoglobuliinin käyttö farmaseuttisen koostumuksen valmistamiseksi syöpäsairauksien hoitamiseksi | |
| JP2023531496A5 (https=) | ||
| JPH11512747A (ja) | 造血幹細胞の動員方法 | |
| JP2024519904A5 (https=) | ||
| CN105521485A (zh) | 脱铁乳铁蛋白组合物及其用于治疗病毒性丙型肝炎的方法 | |
| IL323508A (en) | Methods and uses for treating nausea and vomiting | |
| JP2023537115A5 (https=) | ||
| JP2024546129A5 (https=) |